Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2020

Open Access 01-12-2020 | Febrile Seizure | Study protocol

The FeverApp registry – ecological momentary assessment (EMA) of fever management in families regarding conformity to up-to-date recommendations

Authors: David Martin, Jana Wachtmeister, Kai Ludwigs, Ekkehart Jenetzky

Published in: BMC Medical Informatics and Decision Making | Issue 1/2020

Login to get access

Abstract

Background

Fever is one of the most common symptoms of pediatric consultations and its mismanagement is a health care burden. Guidelines on fever management are incoherent and data on fever management are still missing. This study protocol describes an app-based registry to evaluate the fever management of parents.

Objective

The primary objectives are to assess guideline adherence (primary outcome) and parental confidence in managing fever, and thus to reduce overuse of antipyretics, antibiotics and healthcare providers.
Secondary objectives include creating a “FeverApp” that will enable parents to handle fever safely and to use the FeverApp registry as symptom and fever management diary. Further objectives include developing and testing a symptom-led registry model by app-based acquisition of parental entries of febrile illness cycle data and developing and testing models of how an interactive app-based registry can enable nationwide EMA information to inform science, guideline and policy makers, and the public.

Methods

A FeverApp, guiding parents and carers in handling and documenting fever, will be developed with family pediatricians according to current guidelines and recommended for all parents in Germany. A registry will anonymously document features, management and outcomes of febrile episodes: basic sociodemographic and medical information, initial symptoms, course of fever, pharmacological and non-pharmacological interventions, consultations with doctors, outcomes, fever-associated fears, and app satisfaction.

Results

This app may improve communication quality and health, e.g. asthma and antimicrobial resistance. Results will be published via website www.​feverapp.​de.

Trial registration

This app-based registry protocol is registered in the German Clinical Trials Register (DRKS) with registration number: DRKS00016591.
Literature
1.
go back to reference Sullivan JE, Farrar HC, American Academy of Pediatrics, the Section on Clinical Pharmacology and Therapeutics. Clinical Report--Fever and Antipyretic Use in Children. Pediatrics. 2011;28:2010–3852. Sullivan JE, Farrar HC, American Academy of Pediatrics, the Section on Clinical Pharmacology and Therapeutics. Clinical Report--Fever and Antipyretic Use in Children. Pediatrics. 2011;28:2010–3852.
2.
go back to reference Crocetti M, Moghbeli N, Serwint J. Fever phobia revisited: have parental misconceptions about fever changed in 20 years? Pediatrics. 2001;107(6):1241–6.CrossRef Crocetti M, Moghbeli N, Serwint J. Fever phobia revisited: have parental misconceptions about fever changed in 20 years? Pediatrics. 2001;107(6):1241–6.CrossRef
3.
go back to reference Bertille N, Purssell E, Corrard F, Chiappini E, Chalumeau M. Fever phobia 35 years later: did we fail? Acta Paediatr. 2016;105(1):9–10.CrossRef Bertille N, Purssell E, Corrard F, Chiappini E, Chalumeau M. Fever phobia 35 years later: did we fail? Acta Paediatr. 2016;105(1):9–10.CrossRef
6.
go back to reference Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006;15(6):398–405.CrossRef Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006;15(6):398–405.CrossRef
7.
go back to reference Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, et al. An Epidemiological Investigation of a Sustained High Rate of Pediatric Parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34(4):434–40.CrossRef Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, et al. An Epidemiological Investigation of a Sustained High Rate of Pediatric Parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34(4):434–40.CrossRef
8.
go back to reference Le Bourgeois M, Ferroni A, Leruez-Ville M, Varon E, Thumerelle C, Brémont F, et al. Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study. J Pediatr. 2016;175:47–53.e3.CrossRef Le Bourgeois M, Ferroni A, Leruez-Ville M, Varon E, Thumerelle C, Brémont F, et al. Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study. J Pediatr. 2016;175:47–53.e3.CrossRef
9.
go back to reference Elemraid MA, Thomas MF, Blain AP, Rushton SP, Spencer DA, Gennery AR, et al. Risk factors for the development of pleural empyema in children. Pediatr Pulmonol. 2015;50(7):721–6.CrossRef Elemraid MA, Thomas MF, Blain AP, Rushton SP, Spencer DA, Gennery AR, et al. Risk factors for the development of pleural empyema in children. Pediatr Pulmonol. 2015;50(7):721–6.CrossRef
10.
go back to reference Kang LW, Kidon MI, Chin CW, Hoon LS, Hwee CY, Chong NK. Severe anaphylactic reaction to ibuprofen in a child with recurrent Urticaria. Pediatrics. 2007;120(3):e742–4.CrossRef Kang LW, Kidon MI, Chin CW, Hoon LS, Hwee CY, Chong NK. Severe anaphylactic reaction to ibuprofen in a child with recurrent Urticaria. Pediatrics. 2007;120(3):e742–4.CrossRef
11.
go back to reference Bachmeyer C, Vermeulen C, Habki R, Blay F, Leynadier F. Acetaminophen (paracetamol)-induced anaphylactic shock. South Med J. 2002;95(7):759–60.CrossRef Bachmeyer C, Vermeulen C, Habki R, Blay F, Leynadier F. Acetaminophen (paracetamol)-induced anaphylactic shock. South Med J. 2002;95(7):759–60.CrossRef
12.
go back to reference Hajdu S, Holinka J, Reichmann S, Hirschl AM, Graninger W, Presterl E. Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms. Antimicrob Agents Chemother. 2010;54(10):4078–84.CrossRef Hajdu S, Holinka J, Reichmann S, Hirschl AM, Graninger W, Presterl E. Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms. Antimicrob Agents Chemother. 2010;54(10):4078–84.CrossRef
13.
go back to reference Ahn K-M, Lee M-S, Hong S-J, Lim D-H, Ahn Y-M, Lee H-R, et al. Fever, use of antibiotics, and acute gastroenteritis during infancy as risk factors for the development of asthma in Korean school-age children. J Asthma. 2005;42(9):745–50.CrossRef Ahn K-M, Lee M-S, Hong S-J, Lim D-H, Ahn Y-M, Lee H-R, et al. Fever, use of antibiotics, and acute gastroenteritis during infancy as risk factors for the development of asthma in Korean school-age children. J Asthma. 2005;42(9):745–50.CrossRef
14.
go back to reference Beasley R, Clayton T, Crane J, von Mutius E, Lai CK, Montefort S, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from phase three of the ISAAC programme. Lancet. 2008;372(9643):1039–48.CrossRef Beasley R, Clayton T, Crane J, von Mutius E, Lai CK, Montefort S, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from phase three of the ISAAC programme. Lancet. 2008;372(9643):1039–48.CrossRef
15.
go back to reference Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother. 2001;50(8):391–6.CrossRef Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother. 2001;50(8):391–6.CrossRef
16.
go back to reference Martin DD. Fever: views in Anthroposophic medicine and their scientific validity. Evid Based Complement Alternat Med. 2016;2016:1–13.CrossRef Martin DD. Fever: views in Anthroposophic medicine and their scientific validity. Evid Based Complement Alternat Med. 2016;2016:1–13.CrossRef
17.
go back to reference Ystrom E, Gustavson K, Brandlistuen RE, Knudsen GP, Magnus P, Susser E, Davey Smith G, Stoltenberg C, Surén P, Håberg SE, Hornig M, Lipkin WI, Nordeng H, Reichborn-Kjennerud T. Prenatal Exposure to Acetaminophen and Risk of ADHD. Pediatrics. 2017;140(5):e20163840. https://doi.org/10.1542/peds.2016-3840. Ystrom E, Gustavson K, Brandlistuen RE, Knudsen GP, Magnus P, Susser E, Davey Smith G, Stoltenberg C, Surén P, Håberg SE, Hornig M, Lipkin WI, Nordeng H, Reichborn-Kjennerud T. Prenatal Exposure to Acetaminophen and Risk of ADHD. Pediatrics. 2017;140(5):e20163840. https://​doi.​org/​10.​1542/​peds.​2016-3840.
19.
go back to reference Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1–32.CrossRef Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1–32.CrossRef
20.
go back to reference James S, Rao SV, Granger CB. Registry-based randomized clinical trials--a new clinical trial paradigm. Nat Rev Cardiol. 2015;12(5):312–6.CrossRef James S, Rao SV, Granger CB. Registry-based randomized clinical trials--a new clinical trial paradigm. Nat Rev Cardiol. 2015;12(5):312–6.CrossRef
21.
go back to reference Martin D. Fieberkrämpfe: Hilft Wärme im Fieberanstieg? Zeitschrift für Komplementärmedizin. 2017;9(01):38–41. Martin D. Fieberkrämpfe: Hilft Wärme im Fieberanstieg? Zeitschrift für Komplementärmedizin. 2017;9(01):38–41.
22.
go back to reference Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33(1):116–25.CrossRef Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33(1):116–25.CrossRef
24.
go back to reference Walsh A, Edwards H, Fraser J. Parents’ childhood fever management: community survey and instrument development. J Adv Nurs. 2008;63(4):376–88.CrossRef Walsh A, Edwards H, Fraser J. Parents’ childhood fever management: community survey and instrument development. J Adv Nurs. 2008;63(4):376–88.CrossRef
25.
go back to reference Mace AE. Sample-size determination. R. E. Krieger Pub. Co.; 1974. 248 pages. Mace AE. Sample-size determination. R. E. Krieger Pub. Co.; 1974. 248 pages.
26.
go back to reference von Elm E, Altmann DG, Egger M, Pocock SC, Gøtzsche PC, Vandenbroucke JP, et al. Das Strengthening the Reporting of Observational Studies in Epidemiology (STROBE-) Statement: Leitlinien für das Berichten von Beobachtungsstudien. Der Internist. 2008;49(6):688–93. von Elm E, Altmann DG, Egger M, Pocock SC, Gøtzsche PC, Vandenbroucke JP, et al. Das Strengthening the Reporting of Observational Studies in Epidemiology (STROBE-) Statement: Leitlinien für das Berichten von Beobachtungsstudien. Der Internist. 2008;49(6):688–93.
27.
go back to reference Hussain M, Al-Haiqi A, Zaidan AA, Zaidan BB, Kiah MLM, Anuar NB, et al. The landscape of research on smartphone medical apps: coherent taxonomy, motivations, open challenges and recommendations. Comput Methods Prog Biomed. 2015;122(3):393–408.CrossRef Hussain M, Al-Haiqi A, Zaidan AA, Zaidan BB, Kiah MLM, Anuar NB, et al. The landscape of research on smartphone medical apps: coherent taxonomy, motivations, open challenges and recommendations. Comput Methods Prog Biomed. 2015;122(3):393–408.CrossRef
28.
go back to reference Albrecht U-V. Chances and Risks of Mobile Health Apps (CHARISMHA) [Internet], Medizinische Hochschule Hannover, 2016. urn:nbn:de:gbv:084-16040811153. Available from: http://www.charismha.de. Albrecht U-V. Chances and Risks of Mobile Health Apps (CHARISMHA) [Internet], Medizinische Hochschule Hannover, 2016. urn:nbn:de:gbv:084-16040811153. Available from: http://​www.​charismha.​de.
29.
go back to reference Duke É, Montag C. Smartphone addiction, daily interruptions and self-reported productivity. Addict Behav Rep. 2017;6:90–5.CrossRef Duke É, Montag C. Smartphone addiction, daily interruptions and self-reported productivity. Addict Behav Rep. 2017;6:90–5.CrossRef
30.
go back to reference Gneezy U, Meier S, Rey-Biel P. When and why incentives (Don’t) work to modify behavior. J Econ Perspect. 2011;25(4):191–210.CrossRef Gneezy U, Meier S, Rey-Biel P. When and why incentives (Don’t) work to modify behavior. J Econ Perspect. 2011;25(4):191–210.CrossRef
Metadata
Title
The FeverApp registry – ecological momentary assessment (EMA) of fever management in families regarding conformity to up-to-date recommendations
Authors
David Martin
Jana Wachtmeister
Kai Ludwigs
Ekkehart Jenetzky
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Febrile Seizure
Published in
BMC Medical Informatics and Decision Making / Issue 1/2020
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-020-01269-w

Other articles of this Issue 1/2020

BMC Medical Informatics and Decision Making 1/2020 Go to the issue